Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ludmila Andrade Alves Ferreira
Observed names:
Ferreira, Ludmila Andrade Alves,
L. Ferreira
Institutions:
National Cancer Institute,
National Cancer Institute,
National Cancer Institute
Observed institutions:
Marqués de Valdecilla University Hospital,
National Cancer Institute,
National Cancer Institute,
National Cancer Institute,
Instituto Nacional de Câncer - INCA
ORCID:
0000-0002-7219-644X
Observed ORCID:
0000-0002-7219-644X
OpenAlex ID:
A5083657341
Association between trastuzumab treatment interruption and survival in HER2-positive metastatic breast cancer patients: a retrospective study
2025
·
Ludmila Andrade Alves Ferreira
, Mário Jorge Sobreira da Silva
, et al.
·
Journal of Chemotherapy
·
1
Cost-Effectiveness and Budget Impact of Zolbetuximab Plus Chemotherapy for Advanced HER2-Negative, CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma in Brazil
2026
·
Ramon Antonio Oliveira
, Gilson Dorneles
, et al.
·
Open Science Framework
Alteração do Formato das Diretrizes Clínicas de Adenocarcinoma de Cólon e Reto no SUS
2025
·
Gláucia Teles de Araújo Bueno
, Ludmila Andrade Alves Ferreira
, et al.
·
Epidemiologia e Serviços de Saúde
PDF
Safety profile of dual blockade treatment with trastuzumab and pertuzumab in patients with her2+metastatic breast cancer: real-world study
2024
·
Kariny Gomes Pereira
, Mario Jorge Sobreira da Silva
, et al.
·
Medicina (Ribeirão Preto)
PDF
Impact of musical training in breast cancer patients with post-treatment cognitive, funtional and emotional sequelae
2022
·
J. Anchuelo
, A. De Juan
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
7
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type